Skip to main content

Table 1 Body mass, lean mass, fat mass, total body water throughout the study period

From: Eight weeks of resistance training in conjunction with glutathione and L-Citrulline supplementation increases lean mass and has no adverse effects on blood clinical safety markers in resistance-trained males

Variable

Baseline

Supplementation (week)

4

8

Body Mass (kg)

 Placebo

81.60 ± 3.0

82.10 ± 3.04

82.30 ± 2.96

 CIT-malate

79.20 ± 2.50

79.50 ± 2.52

80.10 ± 2.42

 GSH + CIT

73.60 ± 1.74*

74.60 ± 1.69

74.60 ± 1.73*

Lean Mass (kg)

 Placebo

59.92 ± 10.42

59.93 ± 10.33

59.81 ± 9.81

 CIT-malate

59.43 ± 8.47

59.59 ± 8.46

59.84 ± 7.93

 GSH + CIT

55.70 ± 7.28

56.46 ± 6.91*

56.20 ± 6.93

Fat Mass (kg)

 Placebo

13.10 ± 1.17

13.70 ± 1.19

14.00 ± 1.20

 CIT-malate

11.20 ± 1.04

11.50 ± 0.92

11.90 ± 0.96

 GSH + CIT

9.90 ± 0.71

10.30 ± 0.71

10.60 ± 0.69*

Total Body Water (kg)

 Placebo

48.20 ± 1.31

48.20 ± 1.32

48.40 ± 1.28

 CIT-malate

47.90 ± 1.14

48.10 ± 1.16

48.40 ± 1.14

 GSH + CIT

45.00 ± 0.89

45.50 ± 0.89

45.60 ± 0.89

Δ Lean Mass (kg)

 Placebo

 

0.01 ± −0.09

−0.11 ± 0.61

 CIT-malate

 

0.16 ± − 0.01

0.41 ± − 0.54

 GSH + CIT

 

0.76 ± − 0.37

0.5 ± − 0.35

Δ Total Body Water (kg)

 Placebo

 

0.0 ± 0.01

0.2 ± 0.03

 CIT-malate

 

0.2 ± 0.02

0.3 ± 0.0

 GSH + CIT

 

0.5 ± 0.0

0.6 ± 0.0

Net Δ LM-TBW (kg)

 Placebo

 

0.01 ± − 0.10

−0.79 ± 0.58

 CIT-malate

 

0.04 ± 0.08

0.11 ± − 0.54

 GSH + CIT

 

0.26 ± 0.37

0.10 ± − 0.35

  1. Mean ± SEM, *Significantly different from Placebo (p < 0.05), Δ = change from baseline, Net Δ = difference in the change in lean mass and total body water from baseline, LM lean mass, TBW total body water